272 related articles for article (PubMed ID: 19363621)
1. Gastric cancer in the era of molecularly targeted agents: current drug development strategies.
Arkenau HT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):855-66. PubMed ID: 19363621
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeted agents for gastric and gastroesophageal junction cancer.
Oshima T; Masuda M
Surg Today; 2012 Apr; 42(4):313-27. PubMed ID: 22127535
[TBL] [Abstract][Full Text] [Related]
3. Gastric Carcinoma at the Era of Targeted Therapies.
Dreanic J; Dhooge M; Sion E; Brezault C; Chaussade S; Coriat R
Curr Drug Targets; 2016; 17(15):1818-1826. PubMed ID: 25944013
[TBL] [Abstract][Full Text] [Related]
4. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP
World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635
[TBL] [Abstract][Full Text] [Related]
5. Changing strategies for target therapy in gastric cancer.
Lee SY; Oh SC
World J Gastroenterol; 2016 Jan; 22(3):1179-89. PubMed ID: 26811656
[TBL] [Abstract][Full Text] [Related]
6. Companion diagnostics for the targeted therapy of gastric cancer.
Yoo C; Park YS
World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
[TBL] [Abstract][Full Text] [Related]
7. [Perspectives of the stomach cancer treatment: the introduction of molecular targeted therapy and the hope for cure].
Cheung DY; Kim JK
Korean J Gastroenterol; 2013 Mar; 61(3):117-27. PubMed ID: 23575230
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapies in gastric cancer and future perspectives.
Yazici O; Sendur MA; Ozdemir N; Aksoy S
World J Gastroenterol; 2016 Jan; 22(2):471-89. PubMed ID: 26811601
[TBL] [Abstract][Full Text] [Related]
9. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of advanced gastric cancer: the role of new molecular drugs.
De Vita F; Di Martino N; Fabozzi A; Laterza MM; Ventriglia J; Savastano B; Petrillo A; Gambardella V; Sforza V; Marano L; Auricchio A; Galizia G; Ciardiello F; Orditura M
World J Gastroenterol; 2014 Oct; 20(40):14537-58. PubMed ID: 25356019
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging therapies in unresectable and recurrent gastric cancer.
Jou E; Rajdev L
World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
[TBL] [Abstract][Full Text] [Related]
12. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
13. Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review.
Zagouri F; Papadimitriou CA; Dimopoulos MA; Pectasides D
Cancer Treat Rev; 2011 Dec; 37(8):599-610. PubMed ID: 21676549
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeted therapy for the treatment of gastric cancer.
Xu W; Yang Z; Lu N
J Exp Clin Cancer Res; 2016 Jan; 35():1. PubMed ID: 26728266
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for gastric adenocarcinoma.
Almhanna K
Adv Pharmacol; 2012; 65():437-70. PubMed ID: 22959034
[TBL] [Abstract][Full Text] [Related]
16. Esophagogastric cancer: targeted agents.
Ku GY; Ilson DH
Cancer Treat Rev; 2010 May; 36(3):235-48. PubMed ID: 20122806
[TBL] [Abstract][Full Text] [Related]
17. Molecularly targeted therapies in advanced gastric cancer.
Janjigian YY; Shah MA
Minerva Gastroenterol Dietol; 2011 Mar; 57(1):75-88. PubMed ID: 21372772
[TBL] [Abstract][Full Text] [Related]
18. Molecular targeted treatment and drug delivery system for gastric cancer.
Jiang L; Gong X; Liao W; Lv N; Yan R
J Cancer Res Clin Oncol; 2021 Apr; 147(4):973-986. PubMed ID: 33550445
[TBL] [Abstract][Full Text] [Related]
19. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.
Cappetta A; Lonardi S; Pastorelli D; Bergamo F; Lombardi G; Zagonel V
Crit Rev Oncol Hematol; 2012 Jan; 81(1):38-48. PubMed ID: 21256046
[TBL] [Abstract][Full Text] [Related]
20. Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer.
Chen Z; Li Y; Tan B; Zhao Q; Fan L; Li F; Zhao X
Drugs Today (Barc); 2020 Jul; 56(7):469-482. PubMed ID: 32648857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]